A mobile prostate cancer screening program proved feasible for men in underserved neighborhoods and led to a high rate of ...

Testosterone therapy after prostate cancer surgery does not appear to increase biochemical recurrence (BCR) risk in patients with low-risk disease, investigators report.

A nurse-led mobile healthcare clinic identified a high proportion of clinically significant prostate cancers among men from ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on ...

Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to ...

New research maps the global burden of male cancers from 1990 to 2040, showing how aging, lifestyle, and healthcare access ...

High prostate-specific antigen levels before High-Intensity Focused Ultrasound were linked to higher recurrence and treatment failure in intermediate-risk prostate cancer.

New Data for NUBEQA® Build on Safety and Efficacy Results Across Subgroups of Patients with Metastatic Hormone-Sensitive ...

Despite guidelines addressing overdetection, no significant declines are seen; emphasis on active surveillance approaches is ...

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...

Researchers identified two distinct epigenetic states that emerge during early development, each associated with varying ...